Table of Contents
Executive Summary — 5
SWOT
Analysis — 6
Moldova Pharmaceuticals And Healthcare
Industry SWOT — 6
Pharmaceutical Business Environment
Ratings — 7
Table: Pharmaceutical Business Environment
Ratings — 7
Limits to Potential
Returns — 8
Risks to Realisation Of
Returns — 8
Moldova - Market
Summary — 10
Regulatory Regime — 12
Intellectual Property Rights — 13
Pricing
Regime — 13
Reimbursement Regime — 14
Table: Republic of Moldova – Out-of-pocket Payments for
Healthcare — 14
International Trade
Agreements — 15
Industry
Developments — 17
Epidemiology — 17
Table: Republic of Moldova – Top 10 Causes of
Death — 18
Table: Republic of Moldova – Leading
Causes Of Morbidity As % of Total Disease Burden — 19
Republic of Moldova - Acute Tuberculosis Morbidity (‘000
population) — 19
Table: Disease Burden In
CEE — 20
Healthcare Sector — 21
Table:
Republic of Moldova - Voluntary Health Insurance
Indicators — 21
Primary Care — 22
Secondary Care — 22
Compulsory Health
Insurance — 23
Table: Republic of Moldova – Social
Health Insurance (SHI) Contributions By Source (As % Of
Total) — 24
Table: Republic of Moldova – The
Flat-Rate Contributions for Self-Insured/Per Capita Budget Contributions For
The Unemployed — 24
Pharmaceutical
Industry — 25
Pharmaceutical
Wholesale — 27
Pharmaceutical
Retail — 27
Research and
Development — 28
Medical Devices — 28
Industry Forecast Scenario — 30
Overall Market
Forecast — 30
Table: Moldova – Drug Market
Expenditure, 2003-2013 — 31
Key Growth Factors –
Industry — 32
Table: Moldova – Health Expenditure,
2003-2013 (MDLmn unless otherwise stated) — 33
Prescription Drug Market Forecast — 34
Table: Moldova -
Prescription Drug Market, 2003-2013 (MDLmn unless otherwise
stated) — 35
Patented Drug Market
Forecast — 36
Table: Moldova - Patented Drug Market,
2003-2013 — 36
Generic Drug Market
Forecast — 37
Table: Moldova – Generic Drug Market,
2003-2013 — 38
OTC Drug Market
Forecast — 39
Table: Moldova – OTC Market, 2003-2013
(MDLmn unless otherwise stated) — 39
Pharmaceutical
Export/Import Forecast — 40
Table: Moldova –
Pharmaceutical Trade Balance, 2003-2013 (US$mn) — 41
Other
Healthcare Data Forecasts — 41
Table: Moldova –
Other Health Indicators, 2003-2013 — 41
Key Risks to
BMI’s Forecasts — 42
Competitive
Landscape — 43
Table: Republic Of Moldova – Top 10
Local Manufacturers (H107) — 44
Table: Republic Of Moldova
– Top 10 Manufacturers By Value — 45
Table: Republic
of Moldova – Top 10 Trade, INNs/Combinations And ATC Groups As
Percentages Of Total Market Value (H108) — 46
Company
Profiles — 47
Foreign Companies — 47
Gedeon Richter — 47
Indigenous
Companies — 49
Farmaco — 49
Top
Pharm — 51
BMI Forecast Modelling — 52
How We Generate Our Pharmaceutical Industry Forecasts — 52
Pharmaceutical Business Environment Ratings
Methodology — 53
Ratings Overview — 53
Table: Pharmaceutical Business Environment Indicators — 54
Weighting — 55
Table: Weighting Of
Components — 55
Sources — 55
| 
View Cart
